VPC03090
VPC03090 is an orally active prodrug of S1P1/3 antagonist. VPC03090 is phosphorylated by sphingosine kinase 2 (SK2) to form its active form VPC03090-P. VPC03090 reduces tumor volume in mouse breast cancer models. VPC03090 can be used in research related to breast cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1392202-91-3
- Formule: C19H31NO
- Masse moléculaire:289.46
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
VPC03090 (10 mg/kg; p.o.; single administration) is rapidly phosphorylated to VPC03090-P in C57BL/6J mice[1].
VPC03090 (30 mg/kg; i.p.; single administration) results in undetectable plasma levels of VPC03090-P in sphingosine kinase 2 gene knockout mice, which confirms that sphingosine kinase 2 is essential for the phosphorylation of VPC03090 in vivo[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (female, 6 weeks of age, orthotopic syngeneic model via injection of 1×105 4T1 mammary cancer cells into the fourth mammary gland fat pad)[1]
-
Dosage:6.2 mg/kg/day
-
Administration:i.p.; daily; 14 days
-
Result:Reduced median tumor volume approximately 3-fold compared with vehicle-treated controls.
-
Animal Model:C57BL/6j[1]
-
Dosage:10 mg/kg
-
Administration:p.o.; single dose
-
Result:Appeared in plasma as phosphorylated active form VPC03090-P within 30 minutes post-dose.
Maintained an approximate 1:1 ratio of phosphorylated (VPC03090-P) to alcohol (VPC03090) species for 6 days post-dose.
Had a VPC03090-P half-life of 30 hours.
-
Animal Model:Sphingosine kinase 2 null (hybrid C57BL/6 and SV129 genetic background)[1]
-
Dosage:30 mg/kg
-
Administration:i.p.; single dose
-
Result:Resulted in micromolar-range plasma VPC03090 concentrations, but VPC03090-P was undetectable (below the LC-MS limit of detection of ~2.5 nM).
Chemical Information
-
CAS No. 1392202-91-3
-
Masse moléculaire 289.46
-
Formule C19H31NO
-
SMILES
OCC1(CC(C1)C2=CC=CC(CCCCCCCC)=C2)N
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Kennedy PC, et al. Characterization of a sphingosine 1-phosphate receptor antagonist prodrug. The Journal of pharmacology and experimental therapeutics. 2011 Sep;338(3):879-89. [Content Brief]
[2]. Kornienko A, et al. Toward a Cancer Drug of Fungal Origin. Medicinal research reviews. 2015 Sep;35(5):937-67. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
VPC03090 Related Classifications
HY-116516 Related Classifications
Powered by Bioz